Abstract:AIM:To study the antitumor effect of matrine in human hepatoma G2 (HepG2) cells and its molecular mechanism involved in antineoplastic activities.METHODS:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to detect viability of HepG2 cells. The effect of matrine on cell cycle was detected by fl ow cytometry. Annexin-V-FITC/PI double staining assay was used to detect cellular apoptosis. Cellular morphological changes were observed under an inverted phase contrast microscope. Transmission electron microscopy was performed to further examine ultrastructural structure of the cells treated with matrine. Monodansylcadaverine (MDC) staining was used to detect autophagy. Whether autophagy is blocked by 3-methyladenine (3-MA), an autophagy inhibitor, was evaluated. Expression levels of Bax and Beclin 1 in HepG2 cells were measured by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR).RESULTS:Matrine significantly inhibited the proliferation of HepG2 cells in a dose- and time-dependent manner, and induced G1-phase cell cycle arrest and apoptosis of HepG2 cells in a dose-dependent manner. The total apoptosis rate was 0.14% for HepG2 cells not treated with matrine. In contrast, the apoptosis rate was 28.91%, 34.36% and 38.80%, respectively, for HepG2 cells treated with matrine at the concentration of 0.5, 1.0 and 2.0 mg/mL. The remarkable morphological changes were observed under an inverted phase contrast microscope. Abundant cytoplasmic vacuoles with varying sizes were observed in HepG2 cells treated with matrine. Furthermore, vacuolization in cytoplasm progressively became larger and denser when the concentration of matrine was increased. Electron microscopy demonstrated formation of abundant autophagic vacuoles in HepG2 cells after matrine treatment. When the specific autophagic inhibitor, 3-MA, was applied, the number of autophagic vacuoles greatly decreased. MDC staining showed that the fluorescent density was higher and the number of MDC-labeled particles in HepG2 cells was greater in matrine treatment group than in control group. Fewer autophagic vacuoles were observed in the combined 3-MA and matrine treatment group when 3-MA was added before matrine treatment, indicating that both autophagy and apoptosis are activated when matrine-induced death of hepatoma G2 cells occurs. Real-time quantitative RT-PCR revealed that the expression levels of Bax gene, an apoptosis-related molecule, and Beclin 1 gene which plays a key role in autophagy were higher in matrine treatment group than in control group, indicating that Beclin 1 is involved in matrine-induced autophagy and the pro-apoptotic mechanism of matrine may be related to its upregulation of Bax expression.CONCLUSION:Matrine has potent antitumor activities in HepG2 cells and may be used as a novel effective reagent in treatment of hepatocellular carcinoma.

Inhibition of Proliferation and Influence of Proto-oncogenes Expression by Matrine in C6 Cell

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Induced differentiation by matrine in C6 brain glioma cells

[Effects of Matrine on the Relative Molecules Expression of Proliferation and Apoptosis in K562 Cells].

Effects of Matrine on Proliferation and Differentiation in K-562 Cells

Matrine Inhibits the Invasive Properties of Human Glioma Cells by Regulating Epithelial-to-mesenchymal Transition

Matrine Induces Senescence of Human Glioblastoma Cells Through Suppression of the IGF1/PI3K/AKT/p27 Signaling Pathway.

Effect of Matrine on Inhibiting Proliferation and Inducing Apoptosis of Human Intestinum Crassum Carcinoma HT29 Cells

[Inhibition of invasiveness and expression of heparanase-mRNA in human malignant melanoma cell line A375 by matrine].

[Effects of matrine on proliferation and apoptosis of human renal cell carcinoma cell line GRC-1].

Matrine inhibits proliferation and migration of HepG2 cells by downregulating ERK1/2 signaling pathways

Inhibition of Matrine Against Gastric Cancer Cell Line MNK45 Growth and Its Anti-Tumor Mechanism

Growth Suppression Effect of Matrine on Human Lung Cancer Cell Lines in vitro

Matrine Reduces the Proliferation of A549 Cells Via the P53/p21/pcna/eif4e Signaling Pathway

Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway

Matrine Inhibits the Proliferation and Migration of Lung Cancer Cells Through Regulation of the Protein Kinase B/glycogen Synthase Kinase-3Β Signaling Pathways.

Antitumor Effect of Matrine in Human Hepatoma G2 Cells by Inducing Apoptosis and Autophagy.

Effect of Matrine on Proliferation and HIF-1α,VEGF Expression of A549 Cells

Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing Mirna Expression Profiles